OptimizeRx Holds Steady at 494 as Traders Await a Catalyst Decoy Therapeutics Surges 55 Breakout Potential for DCOY Stock VMAR Slides 995 to 066 as Selling Pressure Intensifies Canadian Pacific Kansas City CP Surges 332 on Heavy Volume Key Levels in Focus